ERK-Dependent Downregulation of Skp2 Reduces Myc Activity With HGF, Leading to Inhibition of Cell Proliferation Through a Decrease in Id1 Expression

Molecular Cancer Research - United States
doi 10.1158/1541-7786.mcr-12-0718
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Rottlerin Exerts Its Anti-Tumor Activity Through Inhibition of Skp2 in Breast Cancer Cells

Oncotarget
Oncology
2016English

Metformin Reduces HGF-induced Resistance to Alectinib via the Inhibition of Gab1

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2020English

A Selective High Affinity MYC-binding Compound Inhibits MYC:MAX Interaction and MYC-dependent Tumor Cell Proliferation

Scientific Reports
Multidisciplinary
2018English

Suppression of Invasion and Metastasis in Aggressive Salivary Cancer Cells Through Targeted Inhibition of ID1 Gene Expression

Cancer Letters
Cancer ResearchOncology
2016English

Salinomycin Induces Cell Death via Inactivation of Stat3 and Downregulation of Skp2

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2013English

Expression of HGF/SF in Mesothelioma Cell Lines and Its Effects on Cell Motility, Proliferation and Morphology

British Journal of Cancer
Cancer ResearchOncology
1998English

A Novel Thyroid Hormone Receptor Isoform, TRβ2-46, Promotes SKP2 Expression and Retinoblastoma Cell Proliferation

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2019English

Cell Cycle-Dependent Regulation of Cytoglobin by Skp2

FEBS Letters
GeneticsCell BiologyMolecular BiologyBiochemistryStructural BiologyBiophysics
2017English

Downregulation of Protein Disulfide‑isomerase A3 Expression Inhibits Cell Proliferation and Induces Apoptosis Through STAT3 Signaling in Hepatocellular Carcinoma

International Journal of Oncology
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy